Lanean...
Expert opinion on the use of cladribine tablets in clinical practice
BACKGROUND: Gaps in current product labels and a lack of detailed clinical guidelines leaves clinicians’ questions on the practical management of patients receiving cladribine tablets for the treatment of relapsing multiple sclerosis (MS) unanswered. We describe a consensus-based programme led by in...
Gorde:
| Argitaratua izan da: | Ther Adv Neurol Disord |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7318823/ https://ncbi.nlm.nih.gov/pubmed/32636933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420935019 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|